TXA reduces the need for blood transfusion in patients undergoing high-risk non-cardiac surgery
When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) or a placebo, patients who received TXA needed significantly fewer blood transfusions and saw…